28168230|t|Safety and efficiency of emergency department interrogation of cardiac devices
28168230|a|Patients with implanted cardiac devices may wait extended periods for interrogation in emergency departments (EDs). Our purpose was to determine if device interrogation could be done safely and faster by ED staff. Prospective randomized, standard therapy controlled, trial of ED staff device interrogation vs. standard process (SP), with 30- day follow-up. Eligibility criteria: ED presentation with a self-report of a potential device related complaint, with signed informed consent. SP interrogation was by company representative or hospital employee. Of 60 patients, 42 (70%) were male, all were white, with a median (interquartile range) age of 71 (64 to 82) years. No patient was lost to follow up. Of all patients, 32 (53%) were enrolled during business hours. The overall median (interquartile range) ED vs. SP time to interrogation was 98.5 (40 to 260) vs. 166.5 (64 to 412) minutes (P=0.013). While ED and SP interrogation times were similar during business hours, 102 (59 to 138) vs. 105 (64 to 172) minutes (P=0.62), ED interrogation times were shorter vs. SP during non-business hours; 97 (60 to 126) vs. 225 (144 to 412) minutes, P=0.002, respectively. There was no difference in ED length of stay between the ED and SP interrogation, 249 (153 to 390) vs. 246 (143 to 333) minutes (P=0.71), regardless of time of presentation. No patient in any cohort suffered an unplanned medical contact or post - discharge adverse device related event. ED staff cardiac device interrogations are faster, and with similar 30- day outcomes, as compared to SP.
28168230	0	6	Safety	T068	C0036043
28168230	11	21	efficiency	T081	C0013682
28168230	25	45	emergency department	T073,T093	C0562508
28168230	46	78	interrogation of cardiac devices	T061	C3163962
28168230	79	87	Patients	T101	C0030705
28168230	93	102	implanted	T033	C2828363
28168230	103	118	cardiac devices	T074	C0018831
28168230	128	136	extended	T082	C0439792
28168230	137	144	periods	T079	C1948053
28168230	149	162	interrogation	T061	C3163962
28168230	166	187	emergency departments	T073,T093	C0562508
28168230	189	192	EDs	T073,T093	C0562508
28168230	227	247	device interrogation	T061	C3163962
28168230	262	268	safely	T068	C0036043
28168230	273	279	faster	T080	C0456962
28168230	283	285	ED	T073,T093	C0562508
28168230	286	291	staff	T097	C0025106
28168230	293	304	Prospective	T062	C0033522
28168230	305	315	randomized	T062	C0034656
28168230	317	344	standard therapy controlled	T062	C0206035
28168230	346	351	trial	T062	C0008976
28168230	355	357	ED	T073,T093	C0562508
28168230	358	363	staff	T097	C0025106
28168230	364	384	device interrogation	T061	C3163962
28168230	389	397	standard	T080	C1442989
28168230	398	405	process	T067	C1522240
28168230	407	409	SP	T067	C1522240
28168230	421	424	day	T079	C0439228
28168230	425	434	follow-up	T058	C1522577
28168230	436	456	Eligibility criteria	T080	C1516637
28168230	458	460	ED	T073,T093	C0562508
28168230	461	473	presentation	T078	C0449450
28168230	481	492	self-report	T062	C2700446
28168230	498	507	potential	T080	C3245505
28168230	508	514	device	T074	C0025080
28168230	523	532	complaint	T201	C3864418
28168230	539	545	signed	T033	C0742766
28168230	546	562	informed consent	T089	C0021430
28168230	564	566	SP	T067	C1522240
28168230	567	580	interrogation	T061	C3163962
28168230	588	610	company representative	T097	C1707453
28168230	614	631	hospital employee	T097	C0025109
28168230	639	647	patients	T101	C0030705
28168230	663	667	male	T032	C0086582
28168230	678	683	white	T098	C0007457
28168230	700	719	interquartile range	T081	C1711350
28168230	721	724	age	T032	C0001779
28168230	742	747	years	T079	C1510829
28168230	752	759	patient	T101	C0030705
28168230	772	781	follow up	T058	C1522577
28168230	790	798	patients	T101	C0030705
28168230	830	844	business hours	T079	C0237877
28168230	866	885	interquartile range	T081	C1711350
28168230	887	889	ED	T073,T093	C0562508
28168230	894	896	SP	T067	C1522240
28168230	905	918	interrogation	T061	C3163962
28168230	962	969	minutes	T079	C0439232
28168230	987	989	ED	T073,T093	C0562508
28168230	994	996	SP	T067	C1522240
28168230	997	1010	interrogation	T061	C3163962
28168230	1011	1016	times	T079	C0449238
28168230	1037	1051	business hours	T079	C0237877
28168230	1089	1096	minutes	T079	C0439232
28168230	1107	1109	ED	T073,T093	C0562508
28168230	1110	1123	interrogation	T061	C3163962
28168230	1135	1142	shorter	T081	C1806781
28168230	1147	1149	SP	T067	C1522240
28168230	1213	1220	minutes	T079	C0439232
28168230	1272	1274	ED	T073,T093	C0562508
28168230	1275	1289	length of stay	T079	C0023303
28168230	1302	1304	ED	T073,T093	C0562508
28168230	1309	1311	SP	T067	C1522240
28168230	1312	1325	interrogation	T061	C3163962
28168230	1365	1372	minutes	T079	C0439232
28168230	1397	1401	time	T079	C0449238
28168230	1405	1417	presentation	T078	C0449450
28168230	1422	1429	patient	T101	C0030705
28168230	1437	1443	cohort	T098	C0599755
28168230	1444	1452	suffered	T184	C0751408
28168230	1456	1465	unplanned	T033	C0243095
28168230	1466	1481	medical contact	T058	C0553618
28168230	1485	1489	post	T079	C0687676
28168230	1492	1501	discharge	T058	C0030685
28168230	1502	1530	adverse device related event	T037	C0521818
28168230	1532	1534	ED	T073,T093	C0562508
28168230	1535	1540	staff	T097	C0025106
28168230	1541	1570	cardiac device interrogations	T061	C3163962
28168230	1575	1581	faster	T080	C0456962
28168230	1604	1607	day	T079	C0439228
28168230	1608	1616	outcomes	T062	C0543472
28168230	1621	1629	compared	T052	C1707455
28168230	1633	1635	SP	T067	C1522240